1. Home
  2. TUYA vs MLTX Comparison

TUYA vs MLTX Comparison

Compare TUYA & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuya Inc. each representing one

TUYA

Tuya Inc. each representing one

HOLD

Current Price

$2.01

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$18.69

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TUYA
MLTX
Founded
2014
2021
Country
China
Switzerland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
TUYA
MLTX
Price
$2.01
$18.69
Analyst Decision
Strong Buy
Buy
Analyst Count
1
12
Target Price
$3.49
$27.50
AVG Volume (30 Days)
1.0M
729.6K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
5.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.76
N/A
Revenue Next Year
$11.90
N/A
P/E Ratio
$27.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.87
$5.95
52 Week High
$2.88
$62.75

Technical Indicators

Market Signals
Indicator
TUYA
MLTX
Relative Strength Index (RSI) 44.29 54.45
Support Level N/A $15.89
Resistance Level $2.48 $19.24
Average True Range (ATR) 0.09 0.84
MACD 0.01 -0.05
Stochastic Oscillator 40.85 57.70

Price Performance

Historical Comparison
TUYA
MLTX

About TUYA Tuya Inc. each representing one

Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness. All the Group's revenue are derived from within the PRC.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: